Sanofi free download, or read Sanofi online

Sanofi Divests Dermik Dermatology Unit to Valeant ...

PRESS RELEASE 1/2 Sanofi Divests Dermik Dermatology Unit to Valeant Pharmaceuticals International, Inc. - Strategic Divestiture to focus on Growth Platforms in the United States and Canada - Paris, France - July 11, 2011 - Sanofi (EURONEXT: SAN and NYSE: SNY) announced today the strategic ...

strategic, states, united, platforms, canada

Sanofi-aventis Press Release - (aflibercept) in Second-line ...

Sanofi-aventis Press Release Sanofi-aventis and Regeneron Report Positive Phase III Results with ZALTRAP ® (aflibercept) in Second-line Metastatic Colorectal Cancer

aventis, aflibercept, second, metastatic, cancer

HIGHLIGHTS OF PRESCRIBING INFORMATION

sanofi-aventis Subject: Xyzal Prescribing Information Keywords: Xyzal (levocetirizine dihydochloride) Prescribing Information Created Date: 1/27/2011 12:11:04 PM

prescribing, xyzal, information, dihydochloride, created

Sanofi-aventis to Acquire Genzyme

Sanofi-aventis Genzyme Media Contact : Media Contact : Jean-Marc Podvin Bo Piela +33 1 53 77 44 50 617-768-6579 508-308-9783 Investor Contact : Investor Contact : Sébastien Martel Patrick Flanigan +33 1 53 77 45 45 617-768-6563 617-816-9521 CONFERENCE CALL Sanofi-aventis and Genzyme will host ...

contact, genzyme, investor, media, aventis

ARALEN CHLOROQUINE PHOSPHATE, USP - DESCRIPTION

ARALEN (chloroquine phosphate) Author: sanofi-aventis Subject: ARALEN PI Keywords: ARALEN chloroquine phosphate Created Date: 11/5/2008 4:41:29 PM

aralen, phosphate, chloroquine, created, keywords

Calcimar (calcitonin salmon)

PRODUCT MONOGRAPH CALCIMAR® SOLUTION (Synthetic Calcitonin-Salmon) Calcium Regulator sanofi-aventis Canada Inc. Date of Revision: 2150 St. Elzear Blvd. West May 9, 2006 Laval, Quebec H7L 4A8 Submission Control No.: 105770 s-a Version 1.2 dated February 26, 2007

submission, quebec, laval, elzear, control

PRODUCT MONOGRAPH

PRODUCT MONOGRAPH Pr SUPRAX ® Cefixime tablets, Mfr. Std., 400 mg Cefixime for oral suspension, Mfr. Std., 100 mg/5 mL Antibiotic sanofi-aventis Canada Inc. 2150 St. Elzear Blvd. West Laval, Quebec H7L 4A8 Submission Control No. : 142028 Date of Revision: November 25, 2010 s-a Version 4.0 dated ...

cefixime, control, submission, quebec, 142028

Sanofi